An Individual Case Safety Report (ICSR) is a structured electronic document pertaining to a single suspected adverse drug reaction in an individual patient at a specific point in time. It is internationally referred to as an Individual Case Safety Report, or ICSR, and contains both medical and administrative case data. In EudraVigilance, the ICSR is the submitted data unit from which safety information is evaluated.<\/p>\n
The EU ICSR Implementation Guide defines the ICSR as a document that provides the most complete available information about a single case at a specific point in time. The single case itself describes information from a primary source regarding suspected adverse drug reactions or suspected unexpected serious adverse drug reactions following the administration of one or more medicinal products to a patient. The report can therefore begin with concise initial information and be updated through follow-up.<\/p>\n
Core data includes, where available, information on the identifiable patient and reporter, the suspected medicinal product, and the reaction. This is supplemented by, among other things, the course of events, dose, concomitant medication, diagnostics, severity criteria, outcome, medical assessment, and administrative data. While the structure does not prevent all incompleteness, it enables standardized submission and subsequent evaluation of the available information.<\/p>\n
For electronic reporting, the relevant data formats, controlled vocabularies, and terminologies should be used. For ICSRs, the EMA refers to ISO 27953-2:2011 and the implementation modalities of ICH Guideline E2B(R3). If information is later corrected, supplemented, or a report is invalidated, this is not done outside the system but through the designated reporting functions and data fields.<\/p>\n
An ICSR is not a free-text clinical report without a data framework. The structured fields, for example, make it visible whether the report is an initial or follow-up report, its source, and the case number maintained by the marketing authorization holder. Recurring identifiers are essential to ensure that information pertaining to the same patient case is not erroneously counted as new, independent cases.<\/p>\n
The safety profile of a medicinal product is influenced by the reliability of these individual case data. Missing patient details, inconsistent medicinal product identification, or incomprehensible coding limit the assessability of a case. The Implementation Guide therefore requires that all medical and administrative information available to the sender be fully transferred into the relevant E2B(R3) elements and that reports be documented as thoroughly as possible.<\/p>\n
An electronic ICSR does not replace medical judgment. Rather, it serves as the vessel in which validated case information becomes accessible for reporting, follow-up, signal detection, and evaluation. The rationale for a causality or expectedness decision must therefore remain traceable within the case, even if individual standardized data fields facilitate subsequent analysis.<\/p>\n
The Individual Case Safety Report is the content; the safety database is the container. An ICSR describes a specific patient case with the information available at that time. A database stores and manages many such reports, enabling search, exchange, version control, and analysis.<\/p>\n
EudraVigilance facilitates the electronic exchange of ICSRs between the EMA, national competent authorities, marketing authorization holders, and clinical trial sponsors in the European Economic Area. The system also includes mechanisms for message processing as well as query and tracking functions. However, these system functions do not transform the database into a single report.<\/p>\n
The existing entry ‘Safety Database’ refers to the technical and organizational environment for numerous cases. In contrast, ‘Individual Case Safety Report’ refers to the single structured reporting document. Similarly, the terms ‘spontaneous report’ and ‘solicited report’ describe a type of report; they can be the source of an ICSR but are not its format.<\/p>\n
In clinical trials, a reportable safety case must be converted from source documents, visit information, and medical queries into a consistent ICSR structure. Especially with multiple reactions, investigational medicinal products, or study phases, the correct assignment of patient, product, temporal course, and follow-up information is crucial. Inconsistent data fields can impair submission, reconciliation with the investigational site, and signal-related evaluation.<\/p>\n
Full-service CROs like Mediconomics support the creation of Individual Case Safety Reports through case processing, medical data coding, quality controls of E2B(R3) data fields, and coordination of follow-up with investigational sites. For electronic submissions, they can also assist with technical validation, management of amendments, and traceability between the safety database, study documentation, and regulatory reporting.<\/p>\n
Is an ICSR always complete when first submitted electronically?<\/strong><\/p>\n No. An ICSR represents the most complete information available at that time. Medically relevant information received later is incorporated into the case as a follow-up and submitted using the designated reporting functions.<\/p>\n Why are controlled vocabularies used in the ICSR?<\/strong><\/p>\n Standardized terms and formats enable electronic exchange and the evaluation of comparable cases. In particular, they reduce ambiguities in medicinal products, reactions, and administrative information.<\/p>\n Is EudraVigilance itself an Individual Case Safety Report?<\/strong><\/p>\n No. EudraVigilance is the European system for the exchange, management, and analysis of many individual case reports. The ICSR is the individual electronically structured report within it.<\/p>\n An Individual Case Safety Report (ICSR) is a structured electronic document pertaining to a single suspected adverse drug reaction in an individual patient at a specific point in time. It is internationally referred to as an Individual Case Safety Report, or ICSR, and contains both medical and administrative case data. In EudraVigilance, the ICSR is […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[23],"class_list":["post-8063","glossary","type-glossary","status-publish","hentry","glossary-cat-pharmakovigilanz"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/8063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":0,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/8063\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=8063"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=8063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Regulatory References<\/h2>\n
\n